SOURCE: Industrial Info Resources

Industrial Info Resources

December 18, 2012 06:15 ET

Pharma-Biotech Industry Invests More Than $12 Billion in 2012 North American Project Starts, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - Dec 18, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the last moments of 2012 run their course, it is a good time to take a look at the Pharmaceutical-Biotech Industry's capital and maintenance (MRO) project activity for the year. In January, the industry had a whopping $17 billion worth of projects set to launch construction in 2012. Almost a year later, that number has taken a dip to just more than $12 billion worth of projects that actually made it to construction as planned.

Other companies featured: Novartis' (NYSE:NVS), Johnson & Johnson's (NYSE:JNJ), Abbott Laboratories' (NYSE:ABT), GlaxoSmithKline (NYSE:GSK), Merck (NYSE:MRK)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=232071&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147